Marksans Pharma fundamental analysis

MARKSANS

217.62

10.17 (4.90%)
Last updated on 18 May, 2026 | 15:58 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Marksans Pharma Fundamentals

P/E Ratio

26.12

P/B Ratio

3.36

Div. Yield

0.39

Sector P/E

71.32

Sector P/B

3.45

Sec. Div. Yield

0.56

Marksans Pharma Fundamentals is currently trading with a P/E Ratio of 26.12, compared to the sector average of 71.32. Its P/B Ratio stands at 3.36, while the sector’s is 3.45. In terms of returns, the stock offers a Dividend Yield of 0.39%, which is than the sector’s 0.56%.

Marksans Pharma Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Poor

  • quality_check
    Quality

    Good

  • quality_check
    Management

    Good

On its scorecard, Marksans Pharma reflects: Price – Expensive, Growth – Poor, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost